bioRxivImmunologyPreprint
Metabolic Repression of Autophagy Drives Inflammation, Pain, and Malodor in Hidradenitis Suppurativa
Mahendra Pratap KashyapiD, R. SinhaiD, Safiya HaqueiD, Lin JiniD, Tiffiny Mayo, Craig A. ElmetsiD, Chander RamaniD, Mohammad AthariD
Abstract
Hidradenitis suppurativa (HS) is a debilitating and underdiagnosed inflammatory skin disease with limited therapeutic options due to an incomplete understanding of its molecular and immunopathogenic basis. Using an integrated multi-omics approach, we delineate convergent pathways linking dysregulated autophagy, malodour, and pain in HS. Lesional tissues exhibited sustained autophagy repression, marked by increased expression and activation of mTOR and ZKSCAN3, reduced levels of autolysosome-promoting metabolites {beta}-hydroxybutyrate and nicotinamide riboside, and accumulation of fructose-1,6-bisphosphate, a negative regulator of AMPK. Transcriptomic analyses identified cadaverine derivatives as key metabolic drivers of keratinocyte reprogramming, inducing gene networks associated with hyperproliferation, inflammation, fibrosis, nociception, and the characteristic carrion-like odour of HS. Concordantly, ATAC-seq revealed increased chromatin accessibility at loci encoding TRP channels and histamine receptors, consistent with heightened nociceptive signalling. Multi-layered proteomics, phospho-proteomics, kinomics, and spatial proteomics analyses, validated by high-resolution confocal imaging, demonstrated elevated mTOR (Ser2448), ZKSCAN3, and P62, alongside reduced LAMP1, across keratinocytes and immune cell populations including CD4 T cells, CD56 NK cells, and CD68 macrophages. Inhibition of mTOR normalized transcriptional programs and cytokine production linked to NLRP3 inflammasome, restoring tissue homeostasis. Collectively, these findings identify a metabolically reinforced mTOR-ZKSCAN3 axis in autophagy dysregulation and cadaverine-driven epithelial reprogramming as central mechanisms sustaining inflammation, pain, and fibrosis in HS. HighlightsO_LIWe identified BCAAs, BHB, NR, and FBP as key metabolites linked to mTOR activation and autophagy dysregulation in HS. C_LIO_LIPolyamines like cadaverine and putrescine, their acetylated derivatives, LPCs, and endocannabinoid dysregulation likely drive malodor and pain in HS. C_LIO_LICadaverine treatment of Ker-CT cells induces HS-associated gene signatures of inflammation, fibrosis, and pain. C_LIO_LIIdentification of an HS macrophage subpopulation expressing ZKSCAN3 with activated mTOR and impaired autophagy. C_LI
- organism: human
- assay: bulk RNA-seq
- assay: ATAC-seq
- assay: proteomics
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mucosal associated invariant T cells are altered in patients with Hidradenitis Suppurativa and contribute to the inflammatory milieu
C. Gallagher, J. MacMahon, … A. E. Hogan·bioRxiv·Jan 17, 2022
- Mass cytometry identifies dysregulation of circulating and cutaneous immune cells in patients with hidradenitis suppurativa
P. Dimitrion, I. Hamzavi, … Q.-S. Mi·bioRxiv·Jan 27, 2023
- Loss of microbial diversity and body site heterogeneity in individuals with Hidradenitis Suppurativa
A. M. Schneider, L. C. Cook, … A. M. Nelson·bioRxiv·Apr 18, 2019
- NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2
M. P. Kashyap, B. Mishra, … C. Raman·bioRxiv·Oct 31, 2023
- Human Dermal Fibroblast Subpopulations and Epithelial Mesenchymal Transition Signals in Hidradenitis Suppurativa Tunnels are Normalized by Spleen Tyrosine Kinase Antagonism in Vivo
A. Flora, R. Jepsen, … J. W. Frew·bioRxiv·Feb 23, 2023
- A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa
Philip E. LeBoit, D. U. Patel, … Margaret M. Lowe·Experimental DermatologyPeer-reviewed·Feb 1, 2025